Results 31 to 40 of about 32,837 (163)

Norovirus GII.4 antibodies in the Portuguese population

open access: yesJournal of Infection in Developing Countries, 2014
Introduction: Norovirus GII.4 is the leading cause of outbreaks of acute and sporadic acute gastroenteritis worldwide. Information on the prevalence of norovirus in Portugal is scarce or null.
João Rodrigo Mesquita   +1 more
doaj   +1 more source

Bee products as alternatives in the treatment of viral infections

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba   +3 more
wiley   +1 more source

Genetic recombination and genotype diversity of norovirus GI in children with acute gastroenteritis in Thailand, 2015-2021

open access: yesJournal of Infection and Public Health
Background: Human norovirus is a predominant etiological agent responsible for acute gastroenteritis across all age groups. Recently, norovirus recombinant strains have been reported as the cause of norovirus outbreaks in several settings and the strains
Pattara Khamrin   +7 more
doaj   +1 more source

Quantifying Protein–Glycan Interactions Using Native Mass Spectrometry

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Interactions between glycan‐binding proteins (GBPs) and carbohydrates (glycans) are essential to many biological processes relevant to human health and disease. For most GBPs, however, their glycan interactome—the repertoire of glycans recognized and their specificities—is poorly defined.
Duong T. Bui   +4 more
wiley   +1 more source

Preventing Foodborne Illness: Norovirus

open access: yesEDIS, 2015
If you have ever had the stomach flu, norovirus was likely the culprit. Norovirus is the most common cause of foodborne illness in the United States and is transmitted through direct person-to-person contact or contaminated objects and food.
Rachael Silverberg   +4 more
doaj   +5 more sources

Methods for ascertaining norovirus disease burdens

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Norovirus is the commonest cause of gastrointestinal disease worldwide in. Infections with norovirus occur in all age groups, however, the highest incidence is in children aged less than five years.
David J. Allen, John P. Harris
doaj   +1 more source

Specific Interactions between Human Norovirus and Environmental Matrices: Effects on the Virus Ecology

open access: yesViruses, 2019
Human norovirus is the major cause of non-bacterial epidemic gastroenteritis. Human norovirus binds to environmental solids via specific and non-specific interactions, and several specific receptors for human norovirus have been reported.
Mohan Amarasiri, Daisuke Sano
doaj   +1 more source

Key Physicochemical Parameters Influencing Reactive Species in Plasma‐Processed‐Air (PPA) Originated From Microwave Discharge

open access: yesPlasma Processes and Polymers, EarlyView.
NO, NO2 and N2O4 were identified in plasma processed air (PPA) by FTIR spectroscopy. NO2 was the dominant long‐living specie with maximum concentration of 10 520 ppm. Critical flowrate is 1.5 SLM for the maximum NOx concentration. A prediction model of NOx generation was made based on specific input energy (SIE).
Yijiao Yao   +5 more
wiley   +1 more source

Risk factors for norovirus infection in healthcare workers during nosocomial outbreaks: a cross-sectional study

open access: yesAntimicrobial Resistance and Infection Control, 2021
Background Norovirus outbreaks cause severe medico-socio-economic problems affecting healthcare workers and patients. The aim of the study was to investigate prevalence of norovirus infection and risk factors for infection in healthcare workers during ...
Kjell Torén   +7 more
doaj   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy